Price trend analysis of Hydrobenzene of China in 2021
An additive used in most processed foods may be linked to colon cancer in mice, a new study suggests.
Emulsifiers are added to foods to improve texture and extend shelf life, the study researchers said.
In mice, regular consumption of two commonly used emulsifiers led to changes in intestinal bacteria that promoted inflammation and colon cancer, the researchers found. The two emulsifiers are polysorbate 80 and Carboxymethylcellulose.
Colon cancer is a leading cause of cancer-related deaths worldwide. There is increasing evidence that intestinal microbes play a role in colon cancer, according to the Georgia State University researchers.
"The incidence of colorectal cancer has been markedly increasing since the mid-20th century," said Emilie Viennois, an assistant professor at Georgia State's Institute for Biomedical Sciences.
"A key feature of this disease is the presence of an altered intestinal microbiota that creates a favorable niche for [the production of tumors]," she said in a university news release.
This same team of researchers previously reported that consumption of dietary emulsifiers causes low-grade inflammation in the intestine.
"The dramatic increase in these diseases has occurred amidst constant human genetics, suggesting a pivotal role for an environmental factor," said Benoit Chassaing, another assistant professor at the institute.
Additional research is needed before emulsifiers can be proven to be considered cancer-causing agents, the researchers said. Also, results of animal studies are often not replicated in humans.
The study results were published Nov. 7 in the journal Cancer Research.
2026-09-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Hydrogenated benzene does not have a deep fall basis
-
Private Equity Firm Acquires Lyons Magnus for About $1 Billion as Beverage and Nutrition Ingredients Consolidate
-
Merck Wins Approval for the World’s First Oral PCSK9 Drug, with Potential Annual Sales of $5 Billion
-
Behind Arkema’s ¥430 Million Claim: A Patent War Over Acrylic Acid Is Tearing Off the “Technical Fig Leaf” of China’s Chemical Giants
-
One Million Tonnes of U.S. Ethane Arrive as China Sets a New Import Record
-
IEA Warns Oil Inventories Are Draining Fast as Chemicals Enter Risk Pricing
-
A $25 Billion Bill Hits Global Companies as Chemical Costs Are Repriced
-
EU Puts Chemicals on Its China De-Risking Watchlist
-
GM Crop Area Hits 216 Million Hectares: Trait-Driven Farming Expands
-
Middle East Polyolefins Hit by Catalyst Constraints: PE/PP Recovery May Be Slower
Recommend Reading
-
Hormuz Is Reopening, But Chemical Logistics May Take Months to Recover
-
Guangxi Huayi Starts 300,000-Tonne VAM Unit: EVA Chain Keeps Expanding
-
Snack Tests Put Red 40, Titanium Dioxide and BHT Back Under Pressure
-
FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Tau PET Imaging
-
FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS, Launching First CELMoD Therapy in Multiple Myeloma
-
Business Society’s August 17, 2026 Melamine Market Outlook: Weak Rebound
-
U.S. Delays Mandatory GRAS Notification Proposal, Pushing Food-Additive Overhaul to Year-End
-
BDO Market Conditions Remain Relatively Stable
-
Business Society’s Market Outlook for Gasoline on August 17, 2026: Fluctuating Trend
-
Supply Reduction, Rising Costs, DOP Price Increase